Understanding delirium in children receiving stem cell transplants
Delirium in Children Undergoing Hematopoietic Stem Cell Transplants
This study is looking at how often kids getting a special type of stem cell transplant experience delirium, which is a sudden change in thinking and awareness, and it aims to find out what might make them more likely to have it, so we can help them recover better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10862588 on NIH RePORTER |
What this research studies
This research investigates the occurrence of delirium, a sudden change in awareness and cognition, in children undergoing hematopoietic stem cell transplantation (HSCT). It aims to identify how common delirium is in this population and what factors may increase the risk of developing it. By studying 1,000 children during the peri-transplant period, the research will also assess how delirium affects their recovery and neurocognitive function. The findings could lead to improved care strategies for these vulnerable patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are scheduled to undergo hematopoietic stem cell transplantation.
Not a fit: Patients who are not undergoing HSCT or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the understanding and management of delirium in children, leading to better health outcomes after stem cell transplants.
How similar studies have performed: While delirium in adults undergoing HSCT has been studied, this research is novel as it focuses specifically on children, an area that has not been previously explored.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Traube, Chani — Weill Medical Coll of Cornell Univ
- Study coordinator: Traube, Chani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.